Morepen Laboratories Ltd
MOREPENLABMorepen Laboratories Ltd
MOREPENLAB
Price Chart
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 43.40 | 3.06 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.51 | 5.11 | 0.71% |
Forecast & Ratings
Detailed ForecastPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Morepen Laboratories Limited is a pharmaceutical company. The Company operates through four segments; they are Active Pharmaceutical Ingredients (API), Domestic Formulations, Diagnostics and Over the Counter (OTC).
Investor Presentation
View olderPeers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 402.01 | 486.29 | 599.19 | 610.23 | 772.21 | 862.55 | 1,200.13 | 1,557.14 | 1,423.66 | 1,544.97 | ||||||||||
Raw Materials | 244.81 | 303.71 | 381.14 | 365.10 | 516.38 | 567.65 | 822.13 | 1,059.36 | 939.26 | 1,439.21 | ||||||||||
| Power & Fuel Cost | 7.41 | 7.64 | 9.84 | 11.08 | 13.18 | 12.56 | 13.00 | 18.93 | 23.78 | |||||||||||
| Employee Cost | 48.79 | 58.29 | 69.69 | 76.53 | 95.36 | 109.91 | 135.59 | 164.25 | 154.68 | |||||||||||
| Selling & Administrative Expenses | 38.70 | 43.72 | 53.46 | 61.08 | 73.30 | 81.73 | 92.40 | 102.60 | 123.94 | |||||||||||
| Operating & Other expenses | 12.70 | 14.56 | 19.96 | 27.99 | 2.80 | 12.70 | 6.43 | 65.01 | 96.33 | |||||||||||
EBITDA | 49.60 | 58.37 | 65.10 | 68.45 | 71.19 | 78.00 | 130.58 | 146.99 | 85.67 | 105.76 | ||||||||||
| Depreciation/Amortization | 38.67 | 35.20 | 33.90 | 34.32 | 39.90 | 36.91 | 30.28 | 27.64 | 27.93 | 29.57 | ||||||||||
| PBIT | 10.93 | 23.17 | 31.20 | 34.13 | 31.29 | 41.09 | 100.30 | 119.35 | 57.74 | 76.19 | ||||||||||
| Interest & Other Items | 8.66 | 10.50 | 7.56 | 4.36 | 2.11 | 1.98 | 1.79 | -7.37 | 1.98 | 1.85 | ||||||||||
| PBT | 2.27 | 12.67 | 23.64 | 29.77 | 29.18 | 39.11 | 98.51 | 126.72 | 55.76 | 74.34 | ||||||||||
| Taxes & Other Items | 0.14 | -0.13 | 0.00 | 0.18 | 0.33 | 5.53 | 1.42 | 25.02 | 17.08 | 21.22 | ||||||||||
| Net Income | 2.13 | 12.80 | 23.64 | 29.59 | 28.85 | 33.58 | 97.09 | 101.70 | 38.68 | 53.12 | ||||||||||
| EPS | 0.05 | 0.28 | 0.53 | 0.66 | 0.64 | 0.75 | 2.16 | 2.19 | 0.78 | 1.04 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Morepen Laboratories Ltd | 59.60 | 3.06 | — |
| Sun Pharmaceutical Industries Ltd | 34.86 | 4.98 | 0.93% |
| Cipla Ltd | 34.74 | 4.10 | 0.70% |
| Dr Reddy's Laboratories Ltd | 21.24 | 4.11 | 0.70% |
Price Comparison
Compare MOREPENLAB with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 1 Mutual Funds holding Morepen Laboratories Ltd
| Funds (Top 1) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
Motilal Oswal Nifty Microcap 250 Index Fund- Direct- Growth Option Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.0000% | Percentage of the fund’s portfolio invested in the stock 0.00% | Change in the portfolio weight of the stock over the last 3 months -0.25% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 188/297 (-14) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
MOREPENLAB has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNews & Opinions
Muthoot Finance, Morepen Laboratories, and Force Motors: What the Charts Say
6 months ago•The Hindu Businessline
Gati Ltd leads losers in ‘A’ group
10 months ago•Business Standard
Morepen Laboratories Ltd leads losers in ‘A’ group
11 months ago•Business Standard
Morepen Laboratories Ltd leads gainers in ‘A’ group
11 months ago•Business Standard
Morepen Laboratories Ltd leads gainers in ‘A’ group
11 months ago•Business Standard
UCO Bank leads gainers in ‘A’ group
11 months ago•Business Standard
MSTC Ltd leads gainers in ‘A’ group
1 year ago•Business Standard
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 18.46%, vs industry avg of 8.45%
Increasing Market Share
Over the last 5 years, market share increased from 0.3% to 0.45%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 5.5%, vs industry avg of 9.82%